Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1997-5-20
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0749-8055
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
259-61
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9034701-Anti-Anxiety Agents,
pubmed-meshheading:9034701-Catatonia,
pubmed-meshheading:9034701-Combined Modality Therapy,
pubmed-meshheading:9034701-Electroconvulsive Therapy,
pubmed-meshheading:9034701-Humans,
pubmed-meshheading:9034701-Lorazepam,
pubmed-meshheading:9034701-Psychiatric Status Rating Scales
|
pubmed:year |
1996
|
pubmed:articleTitle |
Advances in the diagnosis and treatment of catatonia.
|
pubmed:publicationType |
Letter,
Comment
|